BioCryst Pharmaceuticals
(NASDAQ: BCRX)
1.73
-0.06
-3.35%
-0.06
-3.35%
MORE ON BCRX
| 2013 Q1 | 2012 Q4 | 2012 Q3 | 2012 Q2 | 2012 Q1 | |
| Period End Date | 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 03/31/2012 |
| Stmt Source | N/A | N/A | N/A | N/A | 10-Q |
| Stmt Source Date | 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 05/09/2013 |
| Stmt Update Type | Original | Original | Original | Original | Updated |
| Currency Code | USD | USD | USD | USD | USD |
| Assets | |||||
Cash, Equiv and Short Term Investments
|
28.3 | 35.6 | 41.0 | 34.9 | 43.3 |
| Cash and Cash Equivalents | 14.8 | 20.9 | 24.0 | 21.9 | 27.7 |
| Short Term Investments | 13.5 | 14.7 | 17.1 | 13.0 | 15.6 |
| Receivables | 4.3 | 4.6 | 3.8 | 5.1 | 5.9 |
|
Inventories
|
0.0 | 0.0 | 0.3 | 0.3 | 0.3 |
| Finished Goods | 0.0 | 4.0 | 4.0 | 4.0 | 4.0 |
| Inventories Adjustments/Allowances | 0.0 | -4.2 | -4.0 | -4.0 | -4.0 |
| Purchased Components | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 |
| Raw Materials | 0.0 | 0.3 | 0.3 | 0.3 | 0.0 |
| Prepaid Assets and Others | 1.8 | 1.1 | 0.8 | 0.3 | 0.4 |
| Deferred Current Assets | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 |
| Other Current Assets | 0.0 | 0.0 | 0.0 | 1.7 | 1.7 |
| Total Current Assets | 35.4 | 42.0 | 46.6 | 45.1 | 52.9 |
|
Net Property,Plant,and Equipment
|
0.5 | 0.6 | 0.8 | 0.9 | 1.0 |
|
Gross Property,Plant,and Equipment
|
0.0 | 14.9 | 0.0 | 0.0 | 0.0 |
| Machinery,Furniture/Equipment | 0.0 | 9.6 | 0.0 | 0.0 | 0.0 |
| Leasehold and Improvements | 0.0 | 5.3 | 0.0 | 0.0 | 0.0 |
| Accumulated Depreciation | 0.0 | -14.3 | 0.0 | 0.0 | 0.0 |
| Investments and Advances | 0.0 | 1.2 | 2.5 | 16.4 | 13.1 |
| Deferred Non-Current Assets | 4.9 | 5.0 | 5.1 | 5.2 | 5.3 |
| Other Non-Current Assets | 6.1 | 8.7 | 9.1 | 8.7 | 7.7 |
| Total Non-Current Assets | 11.5 | 15.5 | 17.5 | 31.2 | 27.1 |
| Total Assets | 46.9 | 57.4 | 64.1 | 76.2 | 80.1 |
| Liabilities and Shareholders' Equity | |||||
|
Payables
|
1.1 | 4.0 | 2.3 | 3.3 | 2.1 |
| Accounts Payable | 1.1 | 4.0 | 2.3 | 3.3 | 2.1 |
| Accrued Expenses,Current | 8.7 | 11.9 | 9.0 | 11.7 | 11.7 |
|
Deferred Liabilities,Current
|
1.5 | 1.4 | 1.3 | 4.1 | 2.4 |
| Deferred Revenue,Current | 1.5 | 1.4 | 1.3 | 4.1 | 2.4 |
| Total Current Liabilities | 11.3 | 17.2 | 12.6 | 19.1 | 16.2 |
|
LT Debt and Capital Lease Obligation
|
30.0 | 30.0 | 30.0 | 30.0 | 30.0 |
| Long Term Debt | 30.0 | 30.0 | 30.0 | 30.0 | 30.0 |
|
Deferred Liabilities, Non current
|
5.6 | 5.9 | 6.2 | 6.5 | 6.8 |
| Deferred Revenues,Non-Current | 5.6 | 5.9 | 6.2 | 6.5 | 6.8 |
| Derivative Liabilities | 2.8 | 4.7 | 5.5 | 5.0 | 4.0 |
| Total Non-Current Liabilities and MI | 38.4 | 40.7 | 41.7 | 41.5 | 40.8 |
| Total Liabilities | 49.7 | 57.9 | 54.3 | 60.6 | 56.9 |
|
Capital Stock
|
0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Common Stock | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Retained Earnings | -397.1 | -392.6 | -381.5 | -371.8 | -359.6 |
| Additional Paid in Capital | 393.7 | 391.6 | 390.8 | 387.0 | 382.2 |
| Total Equity | -2.8 | -0.5 | 9.8 | 15.7 | 23.2 |
| Total Liabilities and Equity | 46.9 | 57.4 | 64.1 | 76.2 | 80.1 |
| Ordinary Shares Outstanding | 51.41 | 50.89 | 50.88 | 50.13 | 49.16 |
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.